Home
Scholarly Works
A phase II study of Bortezomib in patients with...
Conference

A phase II study of Bortezomib in patients with mantle cell lymphoma

Authors

Assouline S; Belch A; Sehn L; Kouroukis CT; Gascoyne R; Meyer R; Powers J; Eisenhauer E

Volume

102

Pagination

pp. 902A-903A

Publisher

AMER SOC HEMATOLOGY

Publication Date

November 16, 2003

Name of conference

45th Annual Meeting of the American-Society-of-Hematology

Conference place

SAN DIEGO, CALIFORNIA

Conference start date

December 6, 2003

Conference end date

December 9, 2003

Conference proceedings

BLOOD

Issue

11

ISSN

0006-4971

Contact the Experts team